Upcoming Webinars

High bacterial loads and biofilm impede wound healing and must be removed but are challenging to detect at the point-of-care.

Transform your approach to complex wound care by participating in this program highlighting the accessibility and new science associated with negative pressure would therapy (NPWT).

With a growing, aging population with multiple health issues, chronic wounds are becoming more common, but costs are high and escalating quickly. Health care providers are asked to do more with less. Pressure is building in an already overloaded health care system.

In this Product Navigator, Dr. Michael Desvigne explains the benefits he sees when using Vashe Wound Solution (pure hypochlorous acid) as a standard treatment for non-intact skin in the hospital.

Lower extremity ulcers, especially diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), can be difficult to manage, and wound closure sometimes takes many months to achieve.

Following admission to a facility, medical device–related pressure injuries (MDRPIs) occur more quickly than other types of pressure injuries.

Choice is good, but making the right choice is better.

We all have flora on our skin, but when the skin microbiome is out of balance because of excessive heat and moisture, serious skin problems can result.

This activity provides 1 CME credit / 1 contact hour.
Current evidence links the pathology of wound hard-to-heal wounds directly to commonplace wound biofilms. The normal healing process of wounds may become derailed due to unseen barriers such as pathogenic biofilm. Biofilms are tenacious and house a colony of multispecies microbes, however not detected by the naked eye. Patients are at higher risk of infection, impaired quality of life, and financial burden when delayed healing due to biofilm presence occurs.

Critically ill patients in intensive care units are the most disadvantaged when it comes to maintaining intact skin, starting from day one of their stay. These patients are highly vulnerable to pressure injuries because of limited mobility, the presence of multiple medical devices, and the severity of their disease, including patients with acute respiratory distress syndrome (ARDS).

Compression therapy is the gold standard of treatment for venous leg ulcers (VLUs). When choosing a compression regimen, clinicians should ensure they are choosing a product that provides continuous and consistent therapeutic compression and is comfortable enough for the patient to wear it throughout the entire treatment process.

Wound care clinicians understand the importance of wound cleansing; wounds are warm and moist, creating the perfect breeding ground for bacteria and biofilm.

The COVID-19 outbreak and ensuing pandemic have changed the way wound care professionals treat and serve their patients.

Debridement is an essential part of wound therapy that allows the transition to subsequent therapies in order to promote healing. Whether the goal is granulation tissue formation, epithelialization for wound closure, or to establish enough healing progression to create an adequate wound to allow for surgical closure, debridement is the cornerstone to wound progress, and if not performed will be an impediment to wound progress.

Intertrigo, sometimes called intertriginous dermatitis, is a form of moisture-associated dermatitis that results from prolonged exposure to perspiration in skin folds and areas beneath medical devices. Clinicians caring for patients with intertrigo need something that will treat all causative factors and prevent the condition from worsening. InterDry's moisture wicking technology and antimicrobial silver is designed to keep skin dry and infection free, helping your patients to heal.

The presence of high levels of bacteria hinders wound closure and contributes to delayed healing. Identification and management of bacterial load in acute and chronic wounds is challenging, yet is critical to optimize treatment outcomes. While clinicians assess clinical signs and symptoms of infection in the wound as a proxy for bacterial burden, the variability of these signs and symptoms hinders timely intervention to treat bacteria in wounds. Objective, real-time information on the presence of bacteria in wounds has been lacking until now.

The Alliance of Wound Care Stakeholders presents a roundtable discussion with front line experts as they discuss the challenges and opportunities clinicians now face during this COVID-19 crisis. This pandemic has driven significant change in the health care system disrupting- indeed transforming- wound care practice. We have brought together the multidisciplinary team of wound care- physicians, nurses, podiatrists and physical therapists to address these issues in their practices.

Chronic DFUs are some of the most difficult wounds a clinician can face. It is therefore important to understand the care and interventions that patients with these wounds often need. Clinicians who encounter DFUs in their practice will find this presentation instructive because it demonstrates ways to encourage healing and prevent chronicity in DFUs.

Given the current global situation with COVID-19, many health care providers have had to make changes with how they deliver care in order to protect themselves and their patients from exposure to the virus. To help with this, the Centers for Medicare & Medicaid Services (CMS) has broadened access to Medicare telehealth services so that beneficiaries can receive a wider range of services from their doctors without having to travel to a health care facility. What does this mean for wound care providers?

During this presentation you will briefly learn about the Smith+Nephew PICO™ single-use NPWT device for wound management.